Methylphenidate is likely less effective than placebo for improving imbalance, walking, and fatigue in people with multiple sclerosis.
1 Department of Neurology, Oregon Health & Science University and VA Portland Health Care System, Portland, OR, USA.
Michelle H
MH
Cameron
2 National Center for Rehabilitative Auditory Research, VA Portland Health Care System, Portland, OR, USA.
Garnett
G
McMillan
D000328:Adult; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D005221:Fatigue / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D004856:Postural Balance / Q000187:drug effects; D016896:Treatment Outcome; D016138:Walking; D055815:Young Adult
D000697:Central Nervous System Stimulants; D008774:Methylphenidate